Differential Spatial Approximation between Cholecystokinin Residue 30 and Receptor Residues in Active and Inactive Conformations
- 17 March 2005
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 67 (6), 1892-1900
- https://doi.org/10.1124/mol.105.012179
Abstract
Understanding the structures of active and inactive agonist- and antagonist-bound receptor complexes is of great interest. In this work, we focus on position 30 of cholecystokinin (CCK) and its spatial approximation with the type A CCK receptor. For this, we developed two photoaffinity labeling probes, replacing the naturally occurring tryptophan with p-benzoyl-l-phenylalanine (Bpa) or p-nitro-phenylalanine (NO2-Phe). The Bpa probe was shown to represent an antagonist, whereas the NO2-Phe probe stimulated intracellular calcium as a fully efficacious agonist (EC50 = 81 ± 15 nM). Both ligands bound to the receptor specifically, although with lower affinity than CCK (Ki values: Bpa probe, 270 ± 72 nM; NO2-Phe probe, 180 ± 40 nM). Both probes covalently labeled the receptor in an efficient manner. The Bpa antagonist labeled the receptor in two distinct regions as identified by cyanogen bromide cleavage, with labeled bands migrating at Mr = 25,000 and 4500. The former represented the glycosylated amino-terminal fragment, with the site of attachment further localized by endoproteinase Lys-C cleavage to the region between Asn10 and Lys37. The latter was shown to represent the first extracellular loop using further cleavage and sequencing of the wild-type and a mutant receptor. Following the same approach, the NO2-Phe agonist probe was shown to also label the first extracellular loop region. Radiochemical sequencing identified that the Bpa antagonist probe labeled receptor residue Lys105, whereas the NO2-Phe agonist probe labeled residue Leu99. These data extend our understanding of the molecular basis of binding and the conformational states of this important receptor.Keywords
This publication has 32 references indexed in Scilit:
- Molecular Models for Cholecystokinin-A ReceptorBasic & Clinical Pharmacology & Toxicology, 2002
- Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal ProbePublished by Elsevier ,2001
- Structurally Related Peptide Agonist, Partial Agonist, and Antagonist Occupy a Similar Binding Pocket within the Cholecystokinin Receptor: RAPID ANALYSIS USING FLUORESCENT PHOTOAFFINITY LABELING PROBES AND CAPILLARY ELECTROPHORESISPublished by Elsevier ,1999
- Arginine 197 of the cholecystokinin‐A receptor binding site interacts with the sulfate of the peptide agonist cholecystokininProtein Science, 1999
- Identification of a Region of the N-Terminal of the Human CCKA Receptor Essential for the High Affinity Interaction with Agonist CCKBiochemical and Biophysical Research Communications, 1995
- STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORSAnnual Review of Biochemistry, 1994
- Synthesis and biological activity of 2‐phenylethyl ester analogues of C‐terminal heptapeptide of cholecystokinin modified in Trp 30 regionInternational Journal of Peptide and Protein Research, 1991
- Use of a nitrotryptophan-containing peptide for photoaffinity labeling the pancreatic cholecystokinin receptorBiochemistry, 1989
- CHOLECYSTOKININ (PANCREOZYMIN)International Journal of Peptide and Protein Research, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970